Table 1.
NM group, n = 58 | CM group, n = 58 | P value | |
Age in yr | 60.34 ± 1.089 | 60.26 ± 1.029 | 0.954 |
Gender | 0.221 | ||
Male | 38 | 44 | |
Female | 20 | 14 | |
Tumor location | 0.884 | ||
Upper | 12 | 10 | |
Middle | 37 | 38 | |
Lower | 9 | 10 | |
Depth of tumor invasion | 0.616 | ||
pT1 | 22 | 17 | |
pT2 | 7 | 7 | |
pT3 | 28 | 31 | |
pT4 | 1 | 3 | |
Lymph node metastasis | 0.484 | ||
pN0 | 32 | 35 | |
pN1 | 18 | 16 | |
pN2 | 4 | 6 | |
pN3 | 4 | 1 | |
AJCC pathological stage | 0.326 | ||
I | 21 | 18 | |
II | 14 | 21 | |
III | 19 | 18 | |
IV | 4 | 1 | |
Preoperative neoadjuvant chemotherapy/radiotherapy | 0.242 | ||
Yes | 2 | 5 | |
No | 56 | 53 |
CM: Conventional method; NM: Novel method.